GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways

Glioblastoma (GB) is a tumor of the central nervous system characterized by high proliferation and invasiveness. The standard treatment for GB includes radiotherapy and chemotherapy; however, new therapies are needed. Particular attention was given to the role of histone methyltransferase enhancer o...

Descripción completa

Detalles Bibliográficos
Autores principales: Scuderi, Sarah Adriana, Filippone, Alessia, Basilotta, Rossella, Mannino, Deborah, Casili, Giovanna, Capra, Anna Paola, Chisari, Giulia, Colarossi, Lorenzo, Sava, Serena, Campolo, Michela, Esposito, Emanuela, Paterniti, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694970/
https://www.ncbi.nlm.nih.gov/pubmed/36430394
http://dx.doi.org/10.3390/ijms232213915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694970/
https://www.ncbi.nlm.nih.gov/pubmed/36430394
http://dx.doi.org/10.3390/ijms232213915

Ejemplares similares